Lv1
40 积分 2023-06-30 加入
Potent Covalent Irreversible Inhibitor of KRAS G12C IBI351 in Patients with Advanced Solid Tumors: First-In-Human Phase I Study
2天前
已完结
Bile acid synthesis impedes tumor-specific T cell responses during liver cancer
10天前
已完结
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
10天前
已完结
Gut microbial metabolism in ferroptosis and colorectal cancer
12天前
已完结
First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy?
15天前
已完结
A Review of the Diagnosis and Treatment of Metastatic Colorectal Cancer
15天前
已完结
Mechanisms of metastatic colorectal cancer
15天前
已完结
Gut microbiota in colorectal cancer development and therapy
15天前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
17天前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
18天前
已完结
皖公网安备34019202002308
